Skip to main content
. 2024 Jan 2;17:7. doi: 10.1186/s13104-023-06667-7

Table 2.

Associations between generalised and institutional trust in wave 1 (age 15–16) and depression and anxiety symptoms in wave 3 (age 20–21). Results from binary logistic and linear regression models. n = 2,668

Depression symptoms (PHQ-2, cutoff ≥ 3), wave 3
Crudea Model 1b Model 2c Model 3d
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Generalised trust, wave 1 0.65*** 0.53, 0.78 0.79* 0.65, 0.96 0.79* 0.64, 0.97
Institutional trust, wave 1 0.76** 0.64, 0.90 0.93 0.77, 1.11 0.99 0.82, 1.20
Anxiety symptoms (GAD-2, cutoff ≥ 3), wave 3
Crudea Model 1b Model 2c Model 3d
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Generalised trust, wave 1 0.70*** 0.58, 0.85 0.87 0.71, 1.06 0.86 0.69, 1.06
Institutional trust, wave 1 0.80** 0.68, 0.94 0.99 0.83, 1.19 1.04 0.86, 1.26
Depression and anxiety symptoms (PHQ-4, scale 0–12), wave 3
Crudea Model 1b Model 2c Model 3d
b 95% CI b 95% CI b 95% CI b 95% CI
Generalised trust, wave 1 -0.81*** -1.05, -0.58 -0.42*** -0.65, -0.19 -0.45*** -0.70, -0.20
Institutional trust, wave 1 -0.43*** -0.65, -0.21 -0.04 -0.27, 0.18 0.09 -0.15, 0.33

*** p < 0.001 **p < 0.01 *p < 0.05

a Includes one variable at a time, controlling for gender

b Includes generalised trust, gender, parental education, parental country of birth, medication for depression and anxiety, and psychosomatic complaints (all measured in wave 1)

c Includes institutional trust, gender, parental education, parental country of birth, medication for depression and anxiety, and psychosomatic complaints (all measured in wave 1)

d Includes generalised and institutional trust, gender, parental education, parental country of birth, medication for depression and anxiety, and psychosomatic complaints (all measured in wave 1)